Nicole Vitullo is Director of Esperion Therapeutics, Inc.. Currently has a direct ownership of 36,918 shares of ESPR, which is worth approximately $77,896. The most recent transaction as insider was on Jun 15, 2023, when has been sold 5,150 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.9K
0% 3M change
0% 12M change
Total Value Held $77,896

NICOLE VITULLO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 15 2023
BUY
Grant, award, or other acquisition
-
5,150 Added 12.24%
36,918 Common Stock
May 27 2021
BUY
Grant, award, or other acquisition
-
12,376 Added 28.04%
31,768 Common Stock

Also insider at

MRNS
MARINUS PHARMACEUTICALS, INC. Healthcare
NV

Nicole Vitullo

Director
Princeton, NJ

Track Institutional and Insider Activities on ESPR

Follow Esperion Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ESPR shares.

Notify only if

Insider Trading

Get notified when an Esperion Therapeutics, Inc. insider buys or sells ESPR shares.

Notify only if

News

Receive news related to Esperion Therapeutics, Inc.

Track Activities on ESPR